![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Beckett R.P. Whittaker M.
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.8, Iss.3, 1998-03, pp. : 259-282
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Matrix metalloproteinase inhibitors
Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Matrix metalloproteinase inhibitors and cancer
By Lauer-Fields J.L. Fields G.B.
Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 12, 2000-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ongoing trials with matrix metalloproteinase inhibitors
By Brown P.D.
Expert Opinion on Investigational Drugs, Vol. 9, Iss. 9, 2000-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Matrix Metalloproteinase Inhibitors as Anticancer Therapeutics
Current Cancer Drug Targets, Vol. 5, Iss. 4, 2005-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Progress in the Development of Matrix Metalloproteinase Inhibitors
Current Medicinal Chemistry, Vol. 15, Iss. 14, 2008-06 ,pp. :